Join
Live feed
·
INSIDERFilingvia Quantisnow
Takeda Pharmaceutical Company Limited logo

President and CEO Kim Julie So-Young was granted 50,434 units of American Depositary Shares and was granted 22,800 units of Ordinary Shares, decreasing direct ownership by 95% to 22,800 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TAK (Takeda Pharmaceutical Company Limited) and more on Quantisnow.